Premature infant clinical trials
21 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Sensory Optimization of the Hospital Environment
- Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates
- Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)
- Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants
- Multisensory Early Oral Administration of Human Milk (M-MILK) for Very Preterm Infants
- Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
- Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?
- Follow-up Visit of High Risk Infants
- Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
- Generic Database of Very Low Birth Weight Infants
- Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
- Individualized Nutrition to Optimize Preterm Infant Growth and Neurodevelopment
- Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
- Standardized Application of Feeding Evaluations Using SMART Tool
- Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)
- Pressure Targeting During High Flow Therapy in Premature Infants
- Breast-milk Enema Administration to Stimulate Passage of Meconium
- Human Milk Concentrating Device to Optimize Mother's Own Milk
- Early Childhood (2-year) Outcomes Among Former VLBW From the ReDiMOM Trial
- Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT
- Randomized Trial of Enteral Vitamin D Supplementation in Infants < 28 Weeks Gestational Age or <1000 Grams Birth Weight
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Premature infant” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.